Coronary Artery Disease and Myocardial Infarction

Breda Hennessey , Asad Shabbir , Alejandro Travieso , et al

Read time: 23 Mins
CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

José M de la Torre Hernández, Lucio Padilla, Adam Sukiennik, et al

Watch time: 2h 14m (7 videos) (7 videos)

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 95m (4 videos)

Jean-Claude Tardif,

Heather Currie , Christine Williams ,

, Carlo Savini , Marco Di Eusanio ,

Edward T Carreras , Donna M Polk ,

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s

Hans-Willi Breuer ,

Remo Albiero ,

FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Kamal Chitkara , Anthony H Gershlick ,

Media

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

José M de la Torre Hernández, Lucio Padilla, Adam Sukiennik, et al

Watch time: 2h 14m (7 videos) (7 videos)

Marco Valgimigli, Vijay Kunadian, Pascal Vranckx, et al

Ahmet Fuat, Gary Ford, Kausik Ray, et al

Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Watch time: 1h 6m (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

Jean-Claude Tardif,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

Guy Van Camp, Koen Van Bockstal, Enrico Neri, et al

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

ACC 2021: Findings From the RESCUE Trial

Paul M Ridker,

AHA 2020: Findings from the THALES trial — Prof Pierre Amarenco

Pierre Amarenco,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, Connie N Hess,

ESC 2020: Final Results of the EVAPORATE Trial

Matthew J Budoff,

ACC 2020 Wrap Up: An Analysis of the Late-breaking Trials

Joost Daemen, Nicolas M Van Mieghem,

ESC 2015 : Ethnic Differences in Incidences of Coronary Artery Spasm

Hiroaki Shimokawa,

Media

CRT 23: The FAST III Randomized Controlled Trial

Joost Daemen,

Watch time: 7m 6s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
CRT 23: PCI Vs CABG in Left Main CAD With or Without Diabetes: A Pooled Ana

Prakriti Gaba,

Watch time: 4m 19s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

José M de la Torre Hernández, Lucio Padilla, Adam Sukiennik, et al

Watch time: 2h 14m (7 videos) (7 videos)

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 95m (4 videos)

Marco Valgimigli, Vijay Kunadian, Pascal Vranckx, et al

Ahmet Fuat, Gary Ford, Kausik Ray, et al

AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
AHA 22 Late-Breaker Discussion: The PRECISE Trial

Pamela S Douglas, Harriette Van Spall,

Watch time: 14m 57s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
TCT 22: FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD

Yuhei Kobayashi,

Watch time: 07:21
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Watch time: 1h 6m (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Giuseppe Tarantini,

Juan Carlos Kaski, Aernoud Fiolet,

Juan-Pablo Kaski, Peter Libby,

Juan Carlos Kaski, Lina Badimon,

Articles

Innovations in Ultra-low Contrast PCI

Breda Hennessey

,

Asad Shabbir

,

Alejandro Travieso

,

Nieves Gonzalo

,

Javier Escaned

,

Published:

29 March 2023

Citation:

Interventional Cardiology 2023;18:e09.

DOI:

https://doi.org/10.15420/icr.2022.32
  • Views: Views 45
  • Downloads: Downloads 2
  • Read time: 23 Mins

Sex Differences in Calcified Coronary Lesions

Sean Fitzgerald

,

Maria Rubini Gimenez

,

Abdelhakim Allali

,

Ralph Toelg

,

Dmitriy S. Sulimov

,

Volker Geist

,

Adnan Kastrati

,

Holger Thiele

,

Gert Richardt

,

Mohamed Abdel-Wahab

,

Published:

20 January 2023

Citation:

Interventional Cardiology 2023;18:e02.

DOI:

https://doi.org/10.15420/icr.2022.07
  • Views: Views 275
  • Downloads: Downloads 20
  • Read time: 17 Mins

Rotatripsy in Left Main Disease

Dinakar Bootla

,

Pruthvi C Revaiah

,

Navjyot Kaur

,

Yash Paul Sharma

,

Himanshu Gupta

,

Published:

25 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e13.

DOI:

https://doi.org/10.15420/japsc.2021.24
  • Views: Views 675
  • Downloads: Downloads 28
  • Citations: 1
  • Read time: 11 minutes

Lipoprotein(a) and Cardiovascular Disease

Yoshiyasu Minami

,

Daisuke Kinoshita

,

Yusuke Muramatsu

,

Takako Nagata

,

Junya Ako

,

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

DOI:

https://doi.org/10.15420/japsc.2021.31
  • Views: Views 1018
  • Downloads: Downloads 56